http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201944997-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc5bf6d1281c52501b840b0e3530fd78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8d7fc47571d6218839e1d369ea0d699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e5d21a52551bad73cbe3b0388046f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29fa17b7ce51f9f3dd8286d6e5188de3
publicationDate 2019-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201944997-A
titleOfInvention Use of Cestabenamide and Exemestane in the preparation of a combined drug for treating breast cancer and a combined drug
abstract The invention relates to the use of cidabenzamide and exemestane in the preparation of a combination drug for treating breast cancer, a pharmaceutical composition or a combination drug comprising cidabenzamide and exemestane, and a combination of cidaben This amine and exemestane treatment of breast cancer.
priorityDate 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426578655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12136798

Total number of triples: 26.